BioPharma Credit returns with $150m cap raise
BioPharma Credit, the UK closed end investment fund that provides debt capital to the life sciences industry, is back in the market with a $150m capital increase to finance its pipeline of investment commitments.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: